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Objective: To highlight the key differences in history, examination, and management
of pyoderma gangrenosum and necrotizing fasciitis and to outline the importance of
distinguishingthese2conditions.Method:Wepresentacasereportofagentlemanwith
a background of ulcerative colitis having a 1-week history of an erythematous wound
and localized abscess to the right leg that failed to respond to antibiotic treatment and
later on to surgical debridement of a presumed necrotizing fasciitis. Following referral
toourplasticsurgeryunit,adiagnosisofpyodermagangrenosumwasmadeandthiswas
conﬁrmed following a response to steroid therapy within 48 hours. A literature review
of pyoderma gangrenosum cases misdiagnosed for necrotizing fasciitis was carried
out to compare and contrast pitfalls in misdiagnosing these 2 conditions. Results:
Literature review of 10 cases conﬁrmed the association of pyoderma gangrenosum with
inﬂammatory bowel disease, hematological disease, and surgical trauma. The presence
ofnecrotictissueinapyodermagangrenosumlesioncanbeadiagnosticpitfall;although
blood and tissue culture investigations are usually negative in pyoderma gangrenosum,
this may not always be the case. Inﬂammatory markers can be signiﬁcantly high in
pyoderma gangrenosum and pyrexia is not a feature limited to necrotizing fasciitis.
Conclusions: Inappropriate surgical debridement of pyoderma gangrenosum can cause
rapid extension of the lesion by enhancing the posttraumatic response and lead to
potential reconstructive challenges with psychological repercussions. On the contrary,
treatingnecrotizingfasciitiswithimmunosuppressivetherapymayworsenthecondition.
The importance of understanding the pathogenesis, clinical features, and management
of both conditions cannot be overemphasized.
Pyodermagangrenosum(PG)isadermatologicalconditionthatcanbeeasilymistaken
for infective conditions including necrotizing fasciitis (NF). We would like to use our case
report as an example of initial wrong diagnosis and inappropriate management of PG
followed by a literature review of PG cases misdiagnosed for NF. The key differences in
history, examination, and management of these 2 conditions will be highlighted
218BISARYA ET AL
METHODS
We located all articles reported in the English language where PG was mistaken for NF
by conducting a literature search on PubMed using the following key words: necrotizing
fasciitis,pyodermagangrenosum,misdiagnosis,andcasereports.Ninecaseswereidentiﬁed
and analyzed to synthesize our data, which were summarized in table format to highlight
the chronology of clinical progression in each case.
CASE REPORT
J.W. was a 33-year-old male IT analyst whose medical background included ulcerative
colitis for which he was on pentase and predfoam enema. He was referred by the general
practitioner (family physician to the emergency department with a 1-week history of an
erythematous wound to his right lateral leg with no improvement on oral ﬂucloxacillin.
Hospital review revealed development of a “localized abscess,” and associated inﬂam-
matory markers included a White cell count (WCC) 13.4 and Creactive protein (CRP)
179. Subsequently the patient was admitted by the orthopedic team and treated with
intravenousantibiotics(benzylpenicillin,ﬂucloxacillin,andmetronidazole).Fourdayslater
he underwent incision and drainage where the operative ﬁndings conﬁrmed “blood stained
pus.” Two days later, an increase in the WCC to 20.3 and CRP to 283 was observed and a
furtherdebridementofa25×15-cmareawasundertakenwhere“abubblyappearanceofthe
margins, extensive erythema and necrosis of the skin distal to the wound, discharge and fat
necrosis” were noted. Histology conﬁrmed inﬂammation with necrosis of the tissues, but
Gram stain showed no speciﬁc organism and wound swabs only grew coagulative negative
Staphylococcus. The case was discussed with the microbiologists who recommended
treating the patient with a provisional diagnosis of NF. However, as there was no clinical
improvement at this stage, he was referred to our burns and plastic surgery department.
An assessment in theatre found “purple borders around the wound, and subcutaneous
pockets of pus which discharged on palpation.” Histology conﬁrmed “an ulcer and abscess
with acute inﬂammation and ﬁbrosis and granulation tissue which extends to the margins
with no vasculitis or neoplasia.” Microbiology failed to show any growth. Based on these
clinical ﬁndings, histology, and microbiology, a diagnosis of PG was made and the patient
was commenced on prednislone 40 mg. Subsequent review revealed improvement within
48 hours with no extension of the wound, and the patient went on to have a split-skin graft
to cover the previous defect with subsequent full recovery (Fig 1).
RESULTS/ANALYSIS OF THE LITERATURE
Table1 summarizes the English literaturereview of cases where PG has been misdiagnosed
for NF. The association of PG with a medical or family history of inﬂammatory bowel
disease (case Nos. 1, 2, 3, 6, 7, 10), surgical trauma and/or worsening after surgery or even
intravenous cannulation (case Nos. 1 2, 3, 5, 6, 7, 8), and an association with hematological
disease (case No. 9) can all be demonstrated. All cases of PG were initially misdiagnosed
as being infective conditions ranging from abscess to cellulitis or NF and were accordingly
treated with antibiotics, surgical debridement including multiple debridements (case Nos.
6,7), repeated excision for histology sampling (case Nos. 9), and even digit or partial toe
amputations (case Nos. 1, 3).
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Figure 1. Lower limb highlighting worsening of Pyoderma gangrenosum postdebridement.
The presence of necrotic tissue can be a diagnostic pitfall, this is seen, for example, in
case No. 9, where the patient at one point in his clinical course had intense pain, pyrexia,
inﬂamed skin, and necrotic tissue favoring NF as a diagnosis but preoperatively superﬁcial
andmuscularfasciaappearedhealthy.NecrotictissuewasalsoseenincaseNos.3,5,and7.
ThepresentationofcaseNo.4alsoismisleading,wherea58-year-oldwomanpresentswith
extreme right breast pain, swollen red skin that rapidly progresses to a black discoloration
within a few hours and eventually does require excision of necrotic areas and healing by
secondary intention. In any case the presence of necrotic tissue makes the diagnosis of PG
more obscure.
In the cases listed in Table 1, while blood culture and/or tissue culture investigations
including wound swabs yielded no positive microbiology in several instances—thus ex-
cluding an infective etiology—this was not always the case. Case No. 6 grew cultures
that isolated Staphylococcus aureus with mixed growth from an ankle wound that initially
presented with ulcers, erythema, and abscesses but subsequently responded to surgical
debridement only to recur again and be misdiagnosed as NF. This same patient developed
violaceousulcersinanSSG donorsitethatgrew mixedgrowth ofskincommensals;inboth
instances the positive cultures were more likely to be colonizers as this was a case of PG
not NF. In case No. 3, Staphylococcus aureus and Enterobacter cloacae were grown from
a postoperative wound, which had pustules and areas of necrotic tissue but subsequently
all cultures were negative while pustular and vesicular lesions were noted. Case No. 7
also presents a similar diagnostic dilemma between NF or colonized or infected PG with
necrotic tissue.
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Table 2. Comparison of pathology and clinical features of pyoderma gangrenosum and necrotizing
fasciitis.
Pyoderma gangrenosum Necrotizing fasciitis
Pathology
Noninfectious neutrophilic dermatosis Necrotic soft tissue infection
Dermis involved Fascia and subcutaneous fat involved
May have necrotic areas Will have necrosis
Clinical
Strong link with inﬂammatory bowel disease No association with inﬂammatory bowel disease
Slower progression within days Rapid progression
Does not resemble cellulitis Can resemble cellulitis in early stage
Violaceous ulcer edge is typical Violaceous ulcer edge not a typical feature
Unlikely to develop sepsis Septic picture can develop
Unlikely to require ITU care Likely to require ITU care
Worsens with surgery Responds to surgery
Fascial planes have normal resistance to dissection Lack of resistance to blunt dissection of fascial planes
Responds to immunosuppressive therapy Worsens with immunosuppressive therapy
No response to antibiotics and worsens with surgery Should respond to antibiotics and surgery
Usually negative blood and tissue cultures Usually positive blood and tissue cultures
ITU indicates, Intensive Therapy Unit.
The biochemical markers in the PG cases reported earlier do not always follow a
consistent pattern, CRP ranges from 14.5 (case No. 6) to 269 (case No. 9) were noted in
activestagesofthediseaseandsimilarlywhitebloodcellcounthasbeenreportedasnormal
(case No. 6) or raised (case No. 9). Pyrexia is not a sign restricted to NF and this has been
noted in case Nos. 5, 8, 9, and 3 the latter as high as 39.8◦C.
The time scale between initial presentation to making a deﬁnite diagnosis of PG and
initiating appropriate treatment ranged from 2 days to 4 weeks, although case No. 3 had an
approximate 14-week delay in having a correct diagnosis, this was established on a graft
donor site that developed pustular lesions and not on the initial operative site, which by
then had healed. In these cases, the initial response to treatment of PG was noted as early
as a few hours up to within 3 days of treatment. The delay in clinching a proper diagnosis
shows the extent of the diagnostic dilemma at times.
DISCUSSION
Pyoderma gangrenosum versus necrotizing fasciitis
In 1930, Brunsting et al1 reported clinical and experimental observations in 5 cases of
pyoderma (ecthyma) gangrenosum in adults, the condition erroneously being thought to be
astreptococcalorstaphylococcalinfection.1 AnumberofcasesofPGhavebeenreportedin
the literature (Table 2) to be misdiagnosed for NF, despite the fact that the pathophysiology
and management of both conditions are totally different.
Pyoderma gangrenosum is a rare, primarily sterile inﬂammatory neutrophilic
dermatosis2 that may present in ulcerative, pustular, bullous, and vegetative forms.3 This
condition has an incidence of 3 to 10 per million per year4 and it can affect all age groups
with the youngest documented patient being a 3-week-old newborn.5 Women are more
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often affected than men and the peak incidence for adult females is in the third and fourth
decades and for males it is in the ﬁfth decade.6 It is found in up to 5% of patients with
ulcerative colitis and in up to 1.5% of patients with Crohn disease.7,8 It is known to be asso-
ciatedwithsystemicdiseasesuchasrheumatoidarthritis,ankylosingspondylitis,leukemia,
myelodysplasia, lymphoma, and other miscellaneous disorders such as sarcoidosis, human
immunodeﬁciency virus infection, and systemic lupus erythematosus.7,9 Up to 40% of
patients may have PG lesions in the absence of associated disease4 and history of pathergy
whereby lesions are precipitated by trauma is reported in 25% of patients.4
One of the challenges in making a correct diagnosis of PG lies in the fact that it
relies heavily on clinical signs as there are no immunoﬂuorescent markers, and in ad-
dition, histopathology is nonspeciﬁc and changes with progression of the lesion.2,7 The
morphological evolution of PG lesions encompasses perivascular lymphocytic inﬁltration
associated with endothelial swelling, while ulceration, areas of necrosis, infarction, and
abscess formation may be found in the later stages.10 Pyoderma gangrenosum lesions have
a predilection for the pretibial areas, although they can affect any other body site including
oral, genital mucosa, and viscera such as lung or spleen.2 A typical lesion would be a
follicular pustule that ulcerates and is surrounded by erythematous, edematous skin. The
ragged, undermined, and violaceous or bluish ulcer border are distinctive of this condition
andkeyinmakingthediagnosis.2,6 The6diseasecategoriesthatareincludedindifferential
diagnosis of PG are infective such as NF, vascular occlusive or venous disease, vasculitic
processes such as Wegener’s, malignancy such as lymphoma or leukemia, pustular drug
reactions, and exogenous tissue injury such as insect bites.2,11
Necrotizing fasciitis is a relatively uncommon, potentially fatal, poly- or monomicro-
bial infection predominately involving subcutaneous fat, superﬁcial fascia, and deep fascia.
This condition not only is limited to susceptible patients such as the malnourished, obese,
immunocompromised,diabeticpatientsorthosewithmalignantdisease(type1NF)butmay
affectpreviouslyhealthyindividualswhoreportahistoryofonlyminortrauma,suchasafter
penetratinginsectbites(type2NF).12,13 Necrotizingfasciitishasbeendocumentedtooccur
in virtually all anatomical regions of the body but has a predilection for the extremities, the
perineumfollowinganischiorectalorpilonidalabscessandtheabdominalwallsuchasafter
abdominal surgery.12 In a study of 83 patients with NF treated over a 17-year period,14 the
commonest pathogenic aerobes were Staphylococcus aureus followed by Escherichia coli
and then group A streptococci. The predominant anaerobes were Peptostreptococcus spp,
Prevotella, Porphyromonas, Bacteroides fragilis group, and Clostridium spp. Anaerobes
outnumbered aerobes and certain microorganisms were associated with speciﬁc conditions
such as Pseudomonas with immunosuppression and malignancy, Bacteroides spp with
diabetes, and clostridium with trauma.14 Necrotizing fasciitis may present with a patchy
discoloration of the skin and ill-deﬁned erythema that can rapidly be followed by a tense
oedema while vesicles and bullae may appear together with necrosis. Pain is generally
out of proportion to the physical ﬁndings while the patient can rapidly become septic and
systemically unwell.12,15
Diagnosis of NF is guided by clinical features, blood cultures, and Gram stain to
identify causative organisms,16 together with scoring tools such as the Laboratory Risk
Indicator for Necrotizing fasciitis, which takes into account CRP, serum Na+, Cr, glucose,
WCC, and hemoglobin to calculate a low, intermediate, or high risk of NF.17 Magnetic
resonance imaging excludes NF if deep fascial involvement is not demonstrated; however,
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this modality of investigation has its limitations as primarily sensitivity is greater than
speciﬁcity and there are time constraints within which to secure the diagnosis.18 The gold
standardfordiagnosisofNFisdirectinspectionoffasciaatsurgery16 andhistologythatwill
reveal minimal change in epidermis, a lymphohistiocytic inﬁltrate in dermis, suppuration,
with necrosis of superﬁcial fascia and blood vessel thrombosis and oedema in the fascial
planes.12
Clearlythese2conditionshavedifferentpathophysiologyandclinicalfeatures;Table1
comparesandcontrastsPGwithNFtohighlightsalientpointsthatmaypreventmisdiagnosis
of either condition.
CONCLUSION
Although several of the clinical features outlined earlier can be identiﬁed in the literature
review cases, the clinical presentation of either condition may be atypical and this, coupled
with confounding laboratory or histological results, creates diagnostic pitfalls.
The importance of understanding the pathogenesis, clinical features, and manage-
ment of both conditions cannot be overemphasized. Aggressive management of PG with
antibiotics and extensive surgical debridement not only will lead to large tissue defects
with potential reconstructive challenges7 but can cause rapid extension of the lesion by
enhancing the posttraumatic response.19 On the contrary, treating NF with immunosup-
pressive therapy may worsen the condition and some authors recommend corticosteroid
therapy in association with antibiotics in dubious cases.19 The psychological repercussions
of misdiagnosis and incorrect management especially that leading to tissue loss are not to
be underestimated.20 This article highlights how important it is to apply the basic principles
of surgery into clinical practice and formulate a diagnosis on the basis of proper history,
clinical examination, and investigations; it is crucial to reconsider the preliminary working
diagnosis if an expected clinical response is not observed.
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